Saturday 17 October 2026 Export MTD’s income statement to Excel — free account

Mettler-Toledo International, Inc.

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.

1,622.29 16.75 −1.02%

Follow MTD

Alert me

Market cap: $32.8B
P/E: 36.4×
Fwd P/E: 25.5×
Dividend yield: —
F-score: 5/9
Altman Z: 10.23
Beneish M: −2.44
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 35.90

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	7	—	—	1	—	—	—	—	—	5	—	—

Insider Ownership 1.15%

Capital & Financial Ratios $m

Market Cap 32,840.00

Revenue 4,133.88

Net Income 905.61

Free Cash Flow 863.97

Net Debt 2,060.58

Current Ratio 1.12

Debt/Equity 164.70

P/E ratio 36.42

Fwd P/E 25.50

P/S ratio 7.90

P/B ratio 2,545.64

Past 5Y EPS Growth 11.04%

This Y EPS Growth 10.79%

Next Y EPS Growth 9.22%

Next Y revenue growth 5.28%

Next 5Y EPS Growth 10.22%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 59.12%

10-year low 10-year high

P/S against its own 10 years 77.29%

10-year low 10-year high

P/B against its own 10 years 96.46%

10-year low 10-year high

EV/Sales against its own 10 years 77.96%

10-year low 10-year high

EV/FCF against its own 10 years 57.57%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	70	59	67	51
Receivables	664	687	778	731
Inventory	386	342	387	412
Other	111	105	130	153
	1,230	1,194	1,363	1,347

	2023	2024	2025	Q'26
Payables	210	216	267	230
ST’ Debt	192	183	64	67
Other	—	—	—	—
	1,181	1,168	1,198	1,201

Compound Annual Growth %

	10y	5y	3y
Sales	5.33%	5.47%	0.90%
Cash Flow	8.07%	5.69%	3.62%
Earnings	9.44%	7.60%	(0.13%)
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	947	1,027	—	—	—
’25	884	983	1,030	1,130	4,026
’24	926	947	955	1,045	3,872
’23	929	982	942	935	3,788
’22	898	978	986	1,058	3,920
’21	804	924	952	1,037	3,718
’20	649	691	807	938	3,085

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	140	310	—	—	—
’25	194	236	299	226	956
’24	190	258	255	266	968
’23	153	267	264	282	966
’22	91	219	245	304	859
’21	159	246	263	241	909
’20	66	183	225	251	725

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	122	283	—	—	—
’25	177	212	275	184	849
’24	173	234	233	226	866
’23	130	238	244	249	861
’22	72	176	219	272	738
’21	134	226	241	204	805
’20	47	167	206	216	635

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	8.33	11.55	—	—	—
’25	7.81	9.76	10.57	13.98	42.05
’24	8.24	10.37	9.96	11.96	40.48
’23	8.47	9.69	9.21	8.52	35.90
’22	7.55	9.29	9.76	11.86	38.41
’21	6.32	7.85	8.71	9.94	32.78
’20	4.03	5.22	6.68	9.03	24.91

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	291.33	408.97	521.79	500.74	579.40	1,033.40	1,065.55	928.50	1,115.64	946.69	Analyst estimates 2026–2028 Powerpack
	High	434.50	694.48	697.26	873.51	1,228.41	1,714.75	1,699.11	1,615.97	1,546.93	1,525.17
People
People	Employees	14,200	15,400	16,000	16,200	16,500	17,800	18,000	17,300	17,300	18,100
	Revenue/emp, $m	0.18	0.18	0.18	0.19	0.19	0.21	0.22	0.22	0.22	0.22
Income, $m
Income, $m	Revenue	2,508	2,725	2,936	3,009	3,085	3,718	3,920	3,788	3,872	4,026
	Gross margin, %	57.32	57.82	57.38	57.87	58.38	58.41	58.88	59.16	60.06	59.37
	EBT	504	574	652	681	749	949	1,071	974	1,037	1,049
	EBT margin, %	20.10	21.07	22.21	22.65	24.27	25.53	27.31	25.70	26.79	26.05
	Net income	384	376	513	561	603	769	873	789	863	869
	Depreciation	69	76	85	89	99	108	113	121	123	126
Per share, $
Per share, $	Revenue	94.59	105.98	116.42	122.46	129.18	160.74	174.27	173.39	182.47	195.36
	Earnings	14.49	14.62	20.33	22.84	25.24	33.25	38.79	36.10	40.67	42.17
	Cash flow	17.38	20.08	22.41	24.56	30.34	39.29	38.19	44.21	45.63	46.37
	Capex	(4.66)	(4.49)	(5.34)	(3.90)	(3.74)	(4.49)	(5.37)	(4.78)	(4.82)	(5.20)
	Free cash flow	12.72	15.59	17.07	20.66	26.60	34.80	32.82	39.43	40.81	41.18
	Book value	16.40	21.28	23.40	17.13	11.84	7.41	1.10	(6.86)	(5.98)	(1.15)
	Shares, m	27	26	25	25	24	23	22	22	21	21
Valuation, ×
Valuation, ×	P/E	29.05	42.82	27.78	34.67	45.08	50.98	37.63	33.63	30.06	33.01
	P/S	4.47	5.91	4.86	6.48	8.82	10.56	8.39	7.00	6.71	7.14
	P/B	25.75	29.42	24.17	46.32	96.29	229.01	1,326.17	0.00	0.00	0.00
	EV/Sales	4.76	6.21	5.15	6.84	9.22	10.98	8.88	7.53	7.21	7.65
	EV/FCF	35.39	42.23	35.12	40.53	44.80	50.74	47.14	33.13	32.24	36.32
Cash, $m
Cash, $m	Operating cash flow	461	516	565	603	725	909	859	966	968	956
	Capex	(124)	(115)	(135)	(96)	(89)	(104)	(121)	(104)	(102)	(107)
	Free cash flow	337	401	430	508	635	805	738	861	866	849
Balance, $m
Balance, $m	Working capital	309	317	311	355	217	123	227	49	26	165
	Total debt	894	980	1,035	1,291	1,334	1,682	2,015	2,081	2,014	2,152
	Net debt	735	831	857	1,083	1,240	1,583	1,919	2,011	1,955	2,085
	Shareholders’ equity	435	547	590	421	283	171	25	(150)	(127)	(24)
Returns, %
Returns, %	ROA	18.63	15.94	19.84	20.75	21.51	25.04	25.59	23.04	26.17	25.00
	ROIC	28.69	27.65	29.51	30.26	32.18	35.43	36.22	36.26	38.54	33.91
	ROE	75.71	76.56	90.14	111.02	171.37	338.69	889.34	(1,260.59)	(623.59)	(1,154.87)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
A Agilent Technologies, Inc.	$49.5B	34.0×	26.3×	+8.06% (above 0%: growing)	+8.47% (above 0%: growing)	+69.50% (above 0%: growing)	55.48%	23.64%	Compare
IQV IQVIA Holdings Inc.	$44.6B	32.8×	22.3×	+8.74% (above 0%: growing)	−0.65% (below 0%: shrinking)	+23.29% (above 0%: growing)	32.85%	11.58%	Compare
WAT Waters Corporation	$43.6B	109×	44.3×	+113.36% (above 0%: growing)	n/m	+750.00% (above 0%: growing)	44.62%	(5.23%)	Compare
IDXX IDEXX Laboratories, Inc.	$43.1B	39.1×	38.3×	+9.66% (above 0%: growing)	+17.21% (above 0%: growing)	+111.44% (above 0%: growing)	64.04%	34.98%	Compare
ILMN Illumina, Inc.	$40.5B	48.4×	34.7×	+9.44% (above 0%: growing)	−8.05% (below 0%: shrinking)	−18.27% (below 0%: shrinking)	66.44%	21.14%	Compare
MTD Mettler-Toledo International, Inc.	$32.8B	36.4×	25.5×	+4.48% (above 0%: growing)	+18.30% (above 0%: growing)	+33.01% (above 0%: growing)	63.29%	30.61%
DGX Quest Diagnostics Incorporated	$26.4B	24.6×	20.8×	+10.21% (above 0%: growing)	+14.74% (above 0%: growing)	+5.28% (above 0%: growing)	33.75%	15.08%	Compare
LH Labcorp Holdings Inc.	$26.4B	26.2×	19.0×	+5.78% (above 0%: growing)	+28.42% (above 0%: growing)	−42.01% (below 0%: shrinking)	29.80%	12.10%	Compare
GH Guardant Health, Inc.	$22.3B	— (loss-making)	— (loss-making)	+44.33% (above 0%: growing)	n/m	−5.46% (below 0%: shrinking)	65.39%	(38.55%)	Compare
Median of peers	$41.8B	34.0×	26.3×	+9.55%	+11.61%	+14.29%	50.05%	13.59%

All 52 Diagnostics & Research stocks →

Mettler-Toledo International, Inc. (MTD) key facts

Strength: Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
Strength: Net income was $869.2 million, or $42.17 per share (basic), a net margin of 21.6%.
Mettler-Toledo International, Inc. (MTD) is a Diagnostics & Research company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, MTD traded at $1,622.29, a market capitalization of $32.8 billion.
At that price the stock trades at 36.4× trailing-twelve-month earnings and 7.9× sales; its P/E is higher than 59% of its own readings over the past ten years.
Return on equity was −1,154.9% and debt-to-equity 164.70.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 10.23 (safe zone) for fiscal 2025.